US2016052986A1PendingUtilityA1
Humanized il-7 rodents
Est. expiryJun 18, 2032(~5.9 yrs left)· nominal 20-yr term from priority
Inventors:Andrew J. Murphy
A01K 2217/07A01K 2267/0387C07K 14/5418A01K 2227/105A01K 2267/0393A01K 67/0278A01K 2267/0331A01K 2217/052A01K 2267/01A01K 2267/03A01K 2217/072A01K 2207/15C12N 15/09
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Genetically modified non-human animals comprising a human or humanized interleukin-7 (IL-7) gene. Cells, embryos, and non-human animals comprising a human or humanized IL-7 gene. Rodents that express human or humanized IL-7 protein. Genetically modified mice that comprise a human or humanized IL-7-encoding gene in their germline, wherein the human or humanized IL-7-encoding gene is under control of endogenous mouse IL-7 regulatory sequences.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A genetically modified rodent cell whose genome comprises a humanized IL-7 gene, wherein the humanized IL-7 gene comprises human IL-7 exons 2, 3, 4, 5, and 6, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, and wherein the rodent cell is a rat cell or a mouse cell.
2 . The genetically modified rodent cell of claim 1 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus, and the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4 and 5.
3 . The genetically modified rodent cell of claim 1 , wherein the humanized IL-7 gene comprises rodent IL-7 exon 1, and human IL-7 exons 2, 3, 4, 5, and 6.
4 . The genetically modified rodent cell of claim 1 , wherein the rodent cell is a rat cell.
5 . The genetically modified rodent cell of claim 1 , wherein the rodent cell is a mouse cell.
6 . The genetically modified rodent cell of claim 1 , wherein the rodent cell is an embryonic stem (ES) cell.
7 . The genetically modified rodent cell of claim 1 , wherein the rodent cell secretes the IL-7 protein encoded by the humanized IL-7 gene.
8 . A rodent embryo comprising at least one rodent donor cell whose genome comprises a humanized IL-7 gene, wherein the humanized IL-7 gene comprises human IL-7 exons 2, 3, 4, 5, and 6, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, and wherein the rodent embryo is a rat embryo or a mouse embryo.
9 . The rodent embryo of claim 8 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus, and the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4 and 5.
10 . The rodent embryo of claim 8 , wherein the humanized IL-7 gene comprises rodent IL-7 exon 1, and human IL-7 exons 2, 3, 4, 5, and 6.
11 . The rodent embryo of claim 8 , wherein the rodent embryo is a rat embryo.
12 . The rodent embryo of claim 8 , wherein the rodent embryo is a mouse embryo.
13 . The rodent embryo of claim 8 , wherein the rodent donor cell is a rodent embryonic stem (ES) cell.
14 . A tissue of a genetically modified rodent, wherein the rodent comprises in its germline a humanized IL-7 gene, wherein the humanized IL-7 gene comprises human IL-7 exons 2, 3, 4, 5, and 6, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, and wherein the rodent selected from a rat and a mouse.
15 . The tissue of claim 14 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus, and the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4 and 5.
16 . The tissue of claim 14 , wherein the humanized IL-7 gene comprises rodent IL-7 exon 1, and human IL-7 exons 2, 3, 4, 5, and 6.
17 . The tissue of claim 14 , wherein the rodent is a rat.
18 . The tissue of claim 14 , wherein the rodent is a mouse.
19 . The tissue of claim 14 , wherein the tissue is selected from the group consisting of thymic, splenic, epidermal and intestinal tissue.
20 . A DNA construct, comprising from 5′ to 3′,
a nucleic acid sequence homologous to a mouse IL-7 5′ non-coding sequence;
a human genomic sequence comprises human IL-7 exons 2, 3, 4, 5, and 6,
wherein the human genomic sequence does not include a human IL-7 5′ regulatory sequence; and
a nucleic acid sequence homologous to a mouse IL-7 3′ non-coding sequence.
21 . The DNA construct of claim 20 , wherein the nucleic acid sequence homologous to a mouse IL-7 5′ non-coding sequence comprises a region of homology to a mouse IL-7 exon 1 sequence.Join the waitlist — get patent alerts
Track US2016052986A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.